AMRI Glasgow Ltd., located in the United Kingdom, focuses on the aseptic formulation development and manufacture of small batches for early stage clinical trials, complementing AMRI's front-end formulation expertise. This site, which is equipped with a dedicated cytotoxic suite, has extensive technical expertise and experience in the development, scale-up and GMP manufacture of liquid and lyophilized sterile dosage form products and has the ability to work with a variety of compound categories, such as small and large molecules and controlled substances.
Core capabilities of AMRI Glasgow’s sterile injectable drug product formulation and clinical stage manufacturing services include:
Pre-formulation, Formulation & Process Development
Manufacture of Sterile Products for Clinical Trials
Analytical & Ancillary Services